Inovio Pharmaceuticals
INO
#8898
Rank
$0.14 B
Marketcap
$2.07
Share price
2.48%
Change (1 day)
-50.36%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -$2.88

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.88. In 2024 the company made an earnings per share (EPS) of -$3.95 an increase over its 2023 EPS that were of -$6.09.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$2.88-27.09%
2024-$3.95-35.14%
2023-$6.09-56.62%
2022-$14.04-19.54%
2021-$17.4535.9%
2020-$12.84-11.57%
2019-$14.5215.24%
2018-$12.60-2.78%
2017-$12.966.93%
2016-$12.12134.88%
2015-$5.16-29.51%
2014-$7.32-57.34%
2013-$17.16146.55%
2012-$6.9620.83%
2011-$5.76-29.41%
2010-$8.16-48.48%
2009-$15.8410%
2008-$14.4011.11%
2007-$12.96-41.3%
2006-$22.08-66.91%
2005-$66.72110.61%
2004-$31.68-61.63%
2003-$82.56186.67%
2002-$28.80
2001N/A-100%
2000-$23.04-63.64%
1999-$63.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.72-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-$1.25-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.36-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$7.59-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$3.60-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
$6.52-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA